Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.

The Lancet. Neurology·2026
Same author

Fixational Microsaccades in Patients With Parkinson Disease.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026
Same author

Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical Trial.

JAMA neurology·2026
Same author

Closing the Gate Before the Horse is out of the Barn: A Model to Effectively Predict the First Fall in Patients with Parkinson's Disease.

Movement disorders clinical practice·2026
Same author

Phosphorylated alpha-synuclein skin biopsy alters diagnosis in two out of three patients: Initial findings in a tertiary center.

Parkinsonism & related disorders·2026
Same author

Data-driven neurobiological subtyping of Parkinson's disease using diffusion MRI-derived isotropic diffusion.

Neuroradiology·2026

Related Experiment Video

Updated: Jul 11, 2026

Bringing the Clinic Home: An At-Home Multi-Modal Data Collection Ecosystem to Support Adaptive Deep Brain Stimulation
06:32

Bringing the Clinic Home: An At-Home Multi-Modal Data Collection Ecosystem to Support Adaptive Deep Brain Stimulation

Published on: July 14, 2023

Pearls in patient selection for deep brain stimulation.

Ramon L Rodriguez1, Hubert H Fernandez, Ihtsham Haq

  • 1Department of Neurology, University of Florida Movement Disorders Center, McKnight Brain Institute, Gainesville, Florida, USA. ramon.rodriguez@neurology.ufl.edu

The Neurologist
|September 13, 2007
PubMed
Summary

Deep brain stimulation (DBS) is a key treatment for movement and neuropsychiatric disorders. Proper patient selection, considering diagnosis, medication response, and mental health, is crucial for successful DBS outcomes.

More Related Videos

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
09:46

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus

Published on: March 8, 2015

Related Experiment Videos

Last Updated: Jul 11, 2026

Bringing the Clinic Home: An At-Home Multi-Modal Data Collection Ecosystem to Support Adaptive Deep Brain Stimulation
06:32

Bringing the Clinic Home: An At-Home Multi-Modal Data Collection Ecosystem to Support Adaptive Deep Brain Stimulation

Published on: July 14, 2023

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
09:46

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus

Published on: March 8, 2015

Area of Science:

  • Neurology
  • Neurosurgery

Background:

  • Deep brain stimulation (DBS) is a vital therapy for medication-refractory movement and neuropsychiatric disorders.
  • General neurologists and practitioners often participate in screening DBS candidates.
  • Effective patient selection is paramount for successful DBS procedures.

Purpose of the Study:

  • To provide clinicians with essential guidelines for identifying appropriate DBS candidates.
  • To outline critical considerations for referring patients for DBS surgery.

Main Methods:

  • Review of key factors in DBS patient selection.
  • Discussion of essential elements for surgical referral.

Main Results:

  • Key considerations include accurate diagnosis, levodopa responsiveness, cognitive and psychiatric evaluations.
  • Assessment of patient's access to care and realistic expectations is vital.
  • These factors are crucial for optimizing DBS candidacy.

Conclusions:

  • Comprehensive evaluation of diagnosis, medication response, cognitive and psychiatric status, access to care, and patient expectations is essential before DBS.
  • Addressing these elements ensures appropriate patient selection for DBS surgery.